vemurafenib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

Memorial Sloan Kettering Cancer Center (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadmeasurable disease

I am/have/hadcancer

I am/have/hadbraf v600 mutation

I am/have/hadbraf v600e

I am/have/hadmetastasis

I am/have/hadneutrophil count

I am/have/hadgilbert's syndrome

I am/have/hadplatelet count

I am/have/hadtargeted therapy

I am/have/hadprimary tumor

I am/have/hadthyroid cancer

I am/have/hadpet/ct scan

I am/have/hadthyroid carcinoma

I am/have/hadexternal beam radiation therapy

I am/have/hadmalabsorption syndrome

I am/have/hadBRAF

I am/have/hadfollicular thyroid cancer

I am/have/hadcoagulation therapy

I am/have/hadtumor progression

I am/have/hadanticoagulation therapy

added new label for I am/have/had

more

I am looking for

I am looking forvemurafenib

I am looking foravid

I am looking forcopanlisib

I am looking fortotal bilirubin

I am looking forlipase

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers

This study is also being done to find out the highest doses of copanlisib and vemurafenib that, when given in combination, do not cause serious side effects, and whether the study treatment will make radioiodine therapy work better in patients with BRAF-mutant thyroid cancers.

cancer

carcinoma

gilbert's syndrome

plat

platelet count

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.